Importing hemp into the United States requires more than determining whether a product contains less than the federal THC threshold. Hemp imports can fall under the oversight of multiple federal agencies, with the USDA, FDA, DEA, and U.S. Customs and Border Protection (CBP) each having distinct responsibilities. For commercial importers, understanding where those authorities apply, and how they interact at the border, is essential before a shipment is dispatched.
The regulatory environment is also approaching a significant change. The federal definition of hemp is scheduled to change on November 12, 2026, creating additional uncertainty for businesses dealing with certain hemp-derived and intoxicating cannabinoid products. Importers should therefore evaluate their product lines not only against the rules currently in effect but also against the upcoming definition change.
This guide focuses on commercial imports for sale and approaches hemp imports from an operational customs perspective. It explains the federal definition of hemp, the roles of the four primary agencies, the upcoming November 2026 reset, classification considerations, documentation, and the practical compliance issues an importer should address before goods reach the U.S. border.
What Counts as Hemp Under Current U.S. Federal Law
Under current federal law, the starting point for determining whether a product qualifies as hemp is the definition established under 7 U.S.C. § 1639o. The brief states that hemp is defined as Cannabis sativa L. and any part of that plant, including its seeds and derivatives, extracts, cannabinoids, and isomers, provided the applicable delta-9 tetrahydrocannabinol concentration does not exceed the statutory threshold.
The federal definition is important because it establishes the boundary between hemp and marijuana for purposes of federal controlled-substance law. The 2018 Farm Bill removed hemp from the Controlled Substances Act and placed regulatory authority over hemp production with the USDA under 7 CFR Part 990.
The 7 U.S.C. § 1639o definition
The current statutory definition uses a delta-9 THC concentration threshold as a central test for determining whether cannabis material qualifies as hemp. For an importer, this means that the identity of the plant or product alone is not enough to establish its regulatory status. The characteristics and composition of the specific product must also be considered.
This distinction becomes particularly important for finished products and extracts. A business may describe an imported product as a hemp product for commercial purposes, but federal regulators will consider whether it actually satisfies the statutory definition.
Importers should therefore establish the regulatory status of their products before shipment rather than relying solely on supplier descriptions, marketing materials, or product names.
The 0.3% delta-9 THC threshold explained
Under the current federal definition, hemp is subject to a 0.3% delta-9 THC concentration threshold on a dry-weight basis. The threshold is one of the principal factors distinguishing federally lawful hemp from marijuana under the current framework.
For importers, this makes laboratory testing and a reliable Certificate of Analysis (COA) particularly important. A shipment that does not meet the applicable federal threshold may not receive the same treatment as qualifying hemp and can create significant customs and regulatory problems.
The brief also highlights that the federal testing landscape is evolving. USDA enforcement of the requirement that hemp be tested by DEA-registered laboratories has been delayed until December 31, 2026, although state-level requirements may impose stricter testing standards.
Products included in the current definition
The current definition can cover a broad range of hemp and hemp-derived materials and products. These include agricultural hemp, hemp seed, hemp fiber, extracts, cannabinoids, and various finished products derived from qualifying hemp.
The brief identifies several commercial categories that may enter the United States through different regulatory and customs pathways, including:
- Industrial hemp fiber and hurds
- Hemp textiles and yarn
- Hempcrete and construction materials
- Hemp seed for planting
- Hemp seed for food
- Hemp-derived CBD isolate and finished products
- Certain intoxicating hemp derivatives before the November 12, 2026 definition reset
The fact that a product is derived from hemp does not mean every regulatory requirement is identical. Product form and intended use can affect its HTS classification, agency requirements, documentation, and admissibility.
Products excluded from the current definition
Products that exceed the applicable federal THC threshold do not qualify for treatment as hemp under the current definition. The brief also specifically identifies synthetic cannabinoids and over-threshold products among products that cannot simply be treated as hemp because they are marketed or described as hemp-derived.
This is particularly important for importers dealing with products such as delta-8 THC, delta-10 THC, or chemically converted cannabinoids. Their regulatory status requires careful evaluation rather than assuming that the term “hemp-derived” automatically makes a product admissible.
Hemp versus marijuana under federal law
For customs and regulatory purposes, the distinction between hemp and marijuana is fundamental. Hemp was removed from the federal controlled-substance definition through the 2018 Farm Bill, but that does not mean every cannabis-derived product is automatically outside federal controlled-substance regulation. The statutory definition and applicable THC requirements still determine whether material qualifies as hemp.
The distinction also determines which agencies and regulatory requirements become relevant. A product that falls outside the federal hemp definition may enter an entirely different regulatory pathway, making accurate product analysis essential before importation.
The brief further emphasizes that the April 22, 2026 Department of Justice Order placing FDA-approved marijuana drug products and state-licensed medical marijuana into Schedule III does not change the status of hemp that qualifies under 7 U.S.C. § 1639o.
Determining that a product qualifies as hemp is only the beginning of the import compliance process. Hemp imports can involve four major federal agencies, each with a different area of responsibility.
USDA’s role in hemp production and imports
The U.S. Department of Agriculture (USDA) oversees hemp production under the federal regulatory framework established after the 2018 Farm Bill. Its responsibilities include requirements connected with hemp production, testing, and applicable state, tribal, and federal production plans.
For importers, USDA requirements can become particularly important for agricultural hemp and hemp seed, where plant health and production requirements may apply.
FDA’s authority over hemp-derived consumer products
The Food and Drug Administration (FDA) has authority over hemp-derived products that fall within its regulatory areas, including food, dietary supplements, cosmetics, labeling, and health claims.
Importers should therefore avoid treating customs clearance as the only compliance requirement. A shipment may satisfy customs requirements while still presenting FDA compliance issues because of its formulation, labeling, intended use, or marketing claims.
DEA’s residual jurisdiction and where it matters
The Drug Enforcement Administration (DEA) remains relevant where products fall within controlled-substance rules or otherwise move outside the federal definition of hemp. Synthetic cannabinoids and products that do not meet the applicable hemp definition require particular attention.
CBP as enforcement at the border
U.S. Customs and Border Protection (CBP) is the agency importers encounter directly during the customs clearance process. CBP reviews import declarations, documentation, classification, country of origin, and other information necessary to determine whether goods can enter the United States.
For hemp shipments, CBP may also coordinate with USDA, FDA, and DEA when an import raises questions involving their respective authorities.
How the four agencies coordinate
The four-agency structure means hemp importers need to think beyond a single customs entry. USDA requirements can affect agricultural products and testing, FDA requirements can apply to consumer products, DEA can become relevant when controlled-substance issues arise, and CBP administers the border entry process.
The practical implication is straightforward: an importer should determine the regulatory pathway for a product before shipping it to the United States. Establishing the product’s hemp status, classification, documentation, testing, and applicable agency requirements in advance can help reduce the risk of detention or refusal at the border.
The next section examines the November 12, 2026 hemp definition reset, including the products most likely to be affected and what importers should do now to prepare for the change.
The November 12, 2026 Hemp Definition Reset
The federal definition of hemp is scheduled for a significant change on November 12, 2026. For businesses importing hemp and hemp-derived products into the United States, this date is important because the change moves away from the current delta-9 THC standard toward a total tetrahydrocannabinols standard. The result could be a major shift in how certain cannabinoid products are treated under federal law.
The change is particularly relevant to businesses dealing with intoxicating hemp-derived products. Importers should not assume that a product that qualifies as hemp today will necessarily retain the same status after November 12, 2026. Product lines should be evaluated in advance, particularly where they contain delta-8 THC, delta-10 THC, or chemically converted cannabinoids.
What the definition changes from and to
Under the current federal framework, hemp is defined using a 0.3% delta-9 THC threshold on a dry-weight basis. The November 12, 2026 legislative change is scheduled to replace this approach with a total tetrahydrocannabinols standard.
This distinction matters because measuring only delta-9 THC can produce a different regulatory outcome from measuring total tetrahydrocannabinols. Products containing other forms of THC may therefore face a different regulatory analysis once the new definition takes effect.
For importers, the practical issue is timing. A product may currently be handled as hemp but require a completely different compliance strategy after the definition changes. Businesses should therefore evaluate inventory, supplier specifications, laboratory testing, and product formulations well before the new standard becomes effective.
Products at risk under the new definition
The brief specifically identifies delta-8 THC, delta-10 THC, and chemically converted cannabinoids as products that may be affected by the new definition. Many of these products have historically been marketed as hemp-derived products because they could fall within the current delta-9 THC framework.
The change does not mean that every hemp-derived product will become prohibited. The brief specifically identifies CBD, industrial hemp, and hemp seed among products that are not affected by the definition reset in the same way.
Importers should therefore avoid applying a blanket rule to their entire hemp product portfolio. Each product should be assessed based on its formulation, cannabinoid profile, intended use, and applicable federal requirements.
The one-year implementation runway
The period leading up to November 12, 2026 provides businesses with an opportunity to prepare before the new definition becomes effective. For importers, this preparation should begin with a review of every hemp-derived product currently being sourced or planned for import.
Businesses should identify products that may be affected, determine which suppliers and product lines require additional documentation, and assess whether existing testing protocols provide the information needed under the future framework.
This is particularly important for companies with long supply chains. Product development, manufacturing, international transportation, customs clearance, and domestic distribution can all take place over different timeframes. A product that is ordered under the current rules may not necessarily arrive before the new definition takes effect.
USDA and FDA rulemaking obligations
The definition change also has implications for federal agencies. The brief identifies USDA and FDA rulemaking obligations as part of the transition and highlights the importance of monitoring how the agencies implement the legislative change.
For importers, this means the statutory change should not be viewed in isolation. Agency guidance and implementing rules can affect how businesses prepare documentation, testing, labeling, and other compliance procedures.
Businesses should monitor official updates rather than relying solely on older guidance or current supplier practices.
Congressional actions that could modify the outcome
The brief also identifies potential Congressional actions as a factor that could modify the outcome before the new definition takes effect.
This creates an additional reason for importers to monitor developments rather than making irreversible sourcing or inventory decisions too early. However, businesses should plan around the law currently scheduled to take effect while continuing to monitor official changes.
What this means for shipments in transit
The definition reset also raises practical questions for goods that are ordered or shipped before November 12 but arrive afterward. The regulatory treatment of shipments in transit should be evaluated based on the applicable rules and official guidance in effect at the time of importation.
Importers should therefore maintain detailed records showing when goods were manufactured, purchased, shipped, and entered into the United States. For products potentially affected by the new definition, shipment timing can become an important compliance consideration.
Businesses should avoid assuming that simply placing an order or beginning international transportation before November 12 automatically preserves the product’s current regulatory status.
How importers should be preparing now
The brief recommends preparation through product-line evaluation and potential sourcing shifts.
A practical preparation process should begin by identifying products that contain cannabinoids potentially affected by the new total-THC standard. Importers should then review supplier specifications and laboratory testing to determine whether they have sufficient information to evaluate each product under the future framework.
Businesses should also consider:
- Reviewing all current hemp-derived SKUs.
- Identifying delta-8, delta-10, and chemically converted cannabinoid products.
- Reviewing existing Certificates of Analysis.
- Discussing formulation changes with suppliers.
- Evaluating alternative products or sourcing arrangements.
- Reviewing inventory and expected shipment dates.
- Monitoring USDA, FDA, DEA, and CBP updates.
The goal is not simply to prepare for a regulatory change at the border. Importers should assess the entire commercial pathway, from sourcing and manufacturing through international transportation, customs clearance, and domestic distribution.
HTS Classification for Hemp Products
Hemp does not have a single universal Harmonized Tariff Schedule (HTS) classification. The correct tariff classification depends on the form and nature of the imported product. The brief identifies several different HTS classifications associated with hemp products, including seeds, botanicals, fiber, extracts, cosmetics, and technical textiles.
This makes classification an important part of the import process. The fact that a product is legally considered hemp does not determine its HTS code. Customs classification is based on the characteristics and commercial nature of the imported merchandise.
HTS 1207.99 for hemp seeds
Hemp seeds may fall under HTS 1207.99, depending on their characteristics and intended use. Importers should distinguish carefully between seed imported for planting and seed imported for food or other purposes because additional USDA APHIS requirements may apply depending on the intended use.
HTS 1211.90 for medicinal botanicals
Certain hemp-related botanical products may be classified under HTS 1211.90. Importers should not automatically classify every hemp plant material under this heading, however. The correct classification depends on the product’s actual composition, presentation, and intended use.
HTS 5302 for true hemp fiber
HTS 5302 covers true hemp fiber and is relevant to imports consisting of qualifying hemp textile fiber. Classification can differ where the hemp has been further processed into yarn, fabric, or finished textile products.
HTS 3301.90 for essential oils and extracts
Certain hemp essential oils and extracts may fall under HTS 3301.90. The exact classification depends on the composition and characteristics of the imported material.
HTS 3304 for cosmetic applications
Hemp-derived products prepared for cosmetic applications may fall under HTS 3304, depending on their formulation and presentation. Importers should also consider FDA requirements separately because tariff classification does not determine whether a cosmetic product meets FDA requirements.
HTS 5911.10 for technical textiles
The brief identifies HTS 5911.10 for technical hemp textiles. Products made from hemp fiber can move across different HTS chapters depending on their degree of processing and final form, making product-specific classification important.
Classification traps and common errors
One of the most common risks is assuming that “hemp” itself determines the tariff classification. It does not. Hemp seeds, fiber, extracts, cosmetics, textiles, and other products can fall under completely different HTS headings.
Importers should therefore avoid using a generic hemp classification across an entire product catalog. Incorrect classification can result in the wrong duty rate, incorrect tariff treatment, or the wrong regulatory pathway.
Classification should be supported by product specifications, composition information, intended use, and other relevant commercial documentation. Where classification is uncertain, obtaining professional customs advice before the first shipment can help prevent costly corrections after importation.
The next section moves from classification to cost, explaining the duty and tariff treatment that may apply to imported hemp, including MFN duties, Section 301 exposure for Chinese-origin products, USMCA treatment, and the Section 122 bridge tariff.
Duty and Tariff Treatment for Imported Hemp
Once an importer has established that a product qualifies as hemp and determined the appropriate HTS classification, the next step is calculating the duties and tariffs that may apply when the merchandise enters the United States. Hemp products do not have one universal duty rate. The applicable treatment depends on the product’s classification, country of origin, and any additional trade measures that apply to that origin.
The brief highlights several tariff considerations that importers should evaluate, including Most-Favored-Nation (MFN) duty rates, Section 301 tariffs on Chinese-origin goods, USMCA treatment for qualifying Canadian and Mexican goods, and the Section 122 bridge tariff.
MFN duty rates across hemp product categories
The first layer of tariff analysis is the ordinary customs duty associated with the product’s HTS classification. These are generally referred to as MFN duty rates.
Because hemp products can fall under different HTS classifications, their duty rates can vary considerably. Hemp seed, hemp fiber, extracts, cosmetics, and technical textiles should therefore not be assumed to carry the same rate simply because they originate from the same plant.
Importers should determine the applicable HTS classification before calculating the landed cost of a shipment. The classification should reflect the actual imported merchandise, including its composition, degree of processing, and intended use.
The duty calculation should then be combined with any additional tariff measures applicable to the product’s country of origin. This is particularly important for importers sourcing hemp products from China, where Section 301 measures may add another layer of duty.
Section 301 tariff exposure on Chinese-origin hemp
Chinese-origin hemp products may be subject to Section 301 additional duties, depending on their HTS classification and the trade measures applicable to that classification.
For an importer, this means the ordinary MFN rate is not necessarily the final customs duty. A product can have its standard HTS duty rate and then be subject to an additional Section 301 tariff because of its Chinese origin.
Importers should therefore evaluate country of origin alongside classification rather than treating these as separate issues. A change in sourcing location can materially affect the total landed cost even where the imported product itself remains unchanged.
The brief specifically calls for consideration of Section 301 exposure on Chinese-origin hemp, making country-of-origin analysis an important part of the tariff planning process.
USMCA eligibility for Canadian and Mexican origin
Hemp products originating in Canada or Mexico may qualify for preferential treatment under the United States-Mexico-Canada Agreement (USMCA) when the applicable requirements are satisfied.
USMCA eligibility should not be assumed simply because goods are shipped from Canada or Mexico. Importers need to establish that the merchandise actually meets the agreement’s applicable rules of origin and other requirements.
Where preferential treatment applies, it can significantly change the customs duty calculation compared with the standard MFN treatment. Importers should therefore obtain and maintain appropriate origin documentation and ensure their customs entry accurately reflects any claimed preferential treatment.
This makes supplier communication particularly important. Importers should establish the origin of the merchandise before shipment and retain documentation supporting the basis for the USMCA claim.
Section 122 bridge tariff considerations
The brief also identifies the Section 122 bridge tariff as a consideration for hemp importers.
Because additional tariff measures can change the overall cost of an import transaction, businesses should not rely solely on the ordinary HTS duty rate when preparing landed-cost calculations. Importers should review the tariff measures applicable to their specific product and origin at the time of entry.
For businesses importing regularly, this is particularly important when negotiating supplier pricing or setting customer prices. A tariff change can affect margins even when the supplier’s invoice price remains unchanged.
USDA Requirements for Hemp Imports
The U.S. Department of Agriculture (USDA) plays an important role in the federal hemp framework. Under the post-2018 Farm Bill regulatory structure, hemp production is regulated through the U.S. Domestic Hemp Production Program under 7 CFR Part 990.
For importers, USDA requirements become particularly relevant where shipments involve agricultural hemp material, seed, or products connected with plant production.
The U.S. Domestic Hemp Production Program under 7 CFR Part 990
The USDA’s hemp regulatory framework establishes requirements governing the production of hemp, including provisions concerning testing and compliance.
Importers should understand that qualifying as hemp under federal law does not eliminate agricultural or plant-related requirements. A shipment may satisfy the federal THC definition while still requiring additional documentation or inspection depending on the nature of the merchandise.
Businesses importing agricultural hemp products should therefore determine whether USDA requirements apply before the shipment leaves the country of export.
DEA-registered laboratory testing
The brief identifies DEA-registered laboratory testing as part of the USDA hemp compliance framework. The USDA’s enforcement of the requirement that hemp be tested by DEA-registered laboratories has been delayed until December 31, 2026.
This transition period does not mean importers can disregard testing requirements. Businesses should continue to evaluate their laboratory documentation and ensure that their testing arrangements provide reliable evidence of the product’s cannabinoid profile.
Importers should also be aware that state requirements may be stricter than the federal framework. A COA that satisfies one jurisdiction may not necessarily satisfy every requirement applicable to the product’s ultimate destination.
State and tribal hemp production plans
Hemp production may be governed through state or tribal plans approved under the federal framework. These programs can establish requirements that businesses need to consider when dealing with hemp produced or sourced through those jurisdictions.
Importers should therefore obtain sufficient information from suppliers to establish where and how the hemp was produced, particularly when importing agricultural material or seed.
Federal plan applicability
Where state or tribal requirements do not apply, the federal framework may govern hemp production. Importers should establish which regulatory pathway applies to the source material and retain documentation demonstrating compliance.
The practical lesson for importers is that USDA compliance should be assessed based on the nature of the product and its supply chain, rather than assuming that every hemp shipment follows an identical pathway.
FDA Requirements for Hemp-Derived Consumer Products
The FDA has a separate regulatory role when hemp-derived products are imported for use as food, dietary supplements, cosmetics, or other consumer products. The brief specifically highlights FDA jurisdiction, the unresolved CBD framework, labeling and health claims, warning letters, and import alerts.
FDA jurisdiction over food, dietary supplements, and cosmetics
A hemp-derived consumer product can qualify as hemp under federal law and still be subject to FDA requirements.
For example, a food, dietary supplement, or cosmetic containing a hemp-derived ingredient must be evaluated under the rules applicable to that product category. Importers should therefore avoid treating the 0.3% THC threshold as a complete regulatory clearance.
The intended use and claims associated with a product can influence its FDA status. Businesses should review formulations, labeling, packaging, and marketing materials before importing products for U.S. sale.
The CBD regulatory framework and its unresolved status
CBD remains an important area of regulatory uncertainty for businesses importing hemp-derived consumer products. The fact that CBD can be derived from legally defined hemp does not mean that every CBD product is automatically approved for use in foods, supplements, or other regulated products.
Importers should therefore distinguish between the legal status of the source hemp and the regulatory status of the finished consumer product.
Labeling and health claims restrictions
FDA requirements also extend to product labeling and marketing claims. Importers should be particularly careful with claims suggesting that a hemp-derived product can diagnose, treat, cure, or prevent a disease or medical condition.
Product labels, websites, packaging, and promotional materials should be reviewed before importation to ensure that claims do not create an unintended FDA compliance issue.
Enforcement patterns and warning letters
The FDA has used warning letters and other enforcement mechanisms in addressing problematic hemp-derived products and claims.
For importers, these enforcement patterns demonstrate why regulatory review should take place before goods are shipped. Correct customs classification alone does not guarantee that a consumer product is acceptable for entry or sale in the United States.
FDA import alerts
FDA import alerts can also affect the entry of products that raise regulatory concerns. Importers dealing with hemp-derived consumer products should check applicable FDA requirements and monitor relevant import alerts before shipping merchandise.
Where FDA requirements apply, businesses should have their product documentation, labeling, formulation information, and supporting records available for review.
Ultimately, importing hemp-derived consumer products requires coordination between customs classification, USDA requirements, FDA compliance, and the product’s cannabinoid profile. Addressing these requirements before shipment can help prevent costly delays after the merchandise reaches the United States.
The next part will examine DEA jurisdiction and the marijuana boundary, followed by the practical CBP customs clearance process and Certificate of Analysis requirements for hemp imports.
DEA Jurisdiction and the Marijuana Boundary
For hemp importers, one of the most important compliance questions is where federally lawful hemp ends and controlled-substance regulation begins. Although the 2018 Farm Bill removed qualifying hemp from the Controlled Substances Act, products that fall outside the federal hemp definition can still raise DEA concerns. The distinction becomes particularly important for synthetic cannabinoids, products exceeding the applicable THC threshold, and other materials that do not satisfy the statutory definition of hemp.
What DEA regulates and does not regulate for hemp
The DEA’s role should not be interpreted as applying to every product derived from cannabis or hemp. Hemp that satisfies the federal definition under 7 U.S.C. § 1639o is treated differently from marijuana and other controlled substances.
The key issue for an importer is therefore determining whether the merchandise actually qualifies as federally defined hemp. If it does, the product is not automatically treated as a controlled substance simply because it is cannabis-derived.
However, products that fall outside that definition may enter a different regulatory framework. Importers should pay particular attention to the product’s cannabinoid profile, formulation, and method of production rather than relying only on commercial descriptions such as “hemp-derived.”
Synthetic cannabinoids as controlled substances
Synthetic cannabinoids require particular care because the term “hemp-derived” does not necessarily establish that a cannabinoid is federally lawful hemp.
The brief specifically identifies synthetic cannabinoids among products that require consideration under DEA jurisdiction.
Importers should establish the nature and composition of cannabinoid products before shipment and maintain laboratory documentation supporting their analysis. Where a product’s status is unclear, obtaining specialist regulatory advice before export can help prevent a shipment from arriving at the U.S. border without the necessary documentation or authorization.
The April 22, 2026 DOJ Order and what it means
The brief identifies an April 22, 2026 Department of Justice Order concerning marijuana and its placement into Schedule III. Importers should understand that this development does not automatically change the federal treatment of qualifying hemp.
The distinction remains important because hemp qualifying under 7 U.S.C. § 1639o is separate from marijuana under the Controlled Substances Act. Businesses should therefore avoid interpreting changes affecting marijuana as automatically changing the rules for federally defined hemp.
Import and export permits under the new Schedule III framework
Where merchandise falls within the controlled-substance framework rather than the federal definition of hemp, additional DEA requirements may apply. The brief identifies import and export permits as relevant considerations under the new Schedule III framework.
This makes the initial product-status determination particularly important. An importer should establish the regulatory status of the merchandise before arranging international transportation, because controlled-substance requirements can be materially different from those applicable to qualifying hemp.
Why hemp under 7 U.S.C. § 1639o is unaffected
The April 2026 DOJ development does not alter the status of hemp that satisfies the statutory definition under 7 U.S.C. § 1639o.
For businesses importing lawful hemp, the central compliance task remains establishing that the product meets the applicable federal hemp requirements and maintaining documentation that supports that determination.
The CBP Customs Clearance Process for Hemp
Once the importer has established the product’s regulatory status, classification, and documentation requirements, the shipment must still pass through the normal U.S. customs process. U.S. Customs and Border Protection (CBP) is responsible for administering customs clearance at the border and may coordinate with other agencies where a hemp shipment raises USDA, FDA, or DEA issues.
Required documentation
Importers should prepare the documentation necessary to establish the identity, value, origin, classification, and regulatory status of the merchandise.
Depending on the product, documentation may include:
- Commercial invoice
- Packing list
- Bill of lading or air waybill
- Product specifications
- Country-of-origin information
- Applicable permits or certificates
- Certificate of Analysis (COA)
- Supporting documentation for USDA, FDA, or DEA requirements
The exact documents required will vary according to the product and its intended use.
HTS classification declaration
The importer must declare the appropriate HTS classification for the merchandise. As discussed earlier, hemp products can fall under different tariff provisions depending on their form and use.
The importer should ensure that the classification declared to CBP is supported by the product’s actual characteristics. A generic classification based solely on the fact that a product contains hemp may result in incorrect duty treatment or additional customs scrutiny.
COA documentation at import
For products where cannabinoid content is relevant, the Certificate of Analysis provides important evidence of the product’s composition.
Importers should ensure that the COA corresponds to the actual product and, where applicable, the specific batch being imported. The documentation should be readily available if CBP or another participating agency requests evidence of compliance.
Country of origin substantiation
Country of origin is relevant both for customs purposes and for determining whether additional tariff measures apply. Importers should maintain records supporting the declared origin rather than relying solely on the country from which the shipment was exported.
This is particularly important where hemp products move through multiple countries before reaching the United States.
Entry filing through ACE
Commercial imports are processed through the Automated Commercial Environment (ACE), CBP’s electronic system for trade processing. Importers and their customs brokers use the system to submit required entry information and facilitate customs clearance.
Accurate entry information is essential because CBP may use the submitted data to determine whether additional agency review is required.
CBP-USDA-DEA coordination at the border
Hemp imports can involve more than CBP. Depending on the merchandise, CBP may coordinate with USDA, FDA, or DEA to determine whether additional requirements have been satisfied.
This is why importers should complete regulatory checks before the shipment arrives. Resolving an issue at the border can be considerably more difficult than identifying it during the planning stage.
Detention and refusal procedures
If a shipment raises questions about classification, documentation, admissibility, or regulatory compliance, CBP or another participating agency may detain the merchandise while the issue is reviewed.
A detention can create additional storage, transportation, and administrative costs. In more serious cases, merchandise that does not meet applicable requirements may be refused entry.
Having complete documentation and a clear compliance file can help an importer respond efficiently to requests for additional information.
Certificate of Analysis (COA) Requirements
A Certificate of Analysis (COA) is an important piece of documentation for many hemp shipments because it provides laboratory evidence concerning the composition of the product. For importers, a COA can help demonstrate that merchandise meets the applicable hemp requirements and can support the information provided during customs and regulatory review.
What a compliant COA includes
A useful COA should identify the product or batch being tested and provide sufficient laboratory information to establish the results of the relevant testing.
For hemp and cannabinoid products, the report should provide a cannabinoid profile that allows the importer and relevant authorities to evaluate the product against the applicable requirements.
Importers should ensure that the COA is not simply a generic document supplied for an entire product line when batch-specific documentation is required.
ISO/IEC 17025:2017 accreditation
The brief identifies ISO/IEC 17025:2017 accreditation as an important laboratory standard for hemp testing.
Importers should review the laboratory’s credentials and confirm that the testing performed is appropriate for the product being imported.
DEA-registered testing laboratories
The brief also identifies DEA-registered laboratories in connection with hemp testing requirements. As noted earlier, USDA enforcement of the DEA-registration requirement has been delayed until December 31, 2026.
Importers should nevertheless review current requirements and ensure their testing arrangements are capable of supporting the applicable federal and state compliance obligations.
Cannabinoid profile testing
A cannabinoid profile is particularly important for products where THC content determines regulatory status. Testing should provide sufficient information to establish the relevant cannabinoid concentrations and identify products that may fall outside the federal hemp definition.
Contaminant testing
Depending on the product and applicable regulatory requirements, laboratory analysis may also address contaminants and other quality or safety characteristics.
Importers should determine which tests are appropriate for the specific product rather than assuming that a single THC result addresses every regulatory requirement.
Batch-level testing timing
Testing should be connected to the actual merchandise being imported. Batch-level documentation helps establish that the COA accurately represents the shipment rather than a different production run.
For businesses importing repeatedly from the same supplier, maintaining a structured system for matching COAs to individual batches, invoices, and shipments can make customs clearance and regulatory verification considerably easier.
For hemp importers, the most effective approach is to treat the COA as part of a broader compliance file rather than as a standalone document. When combined with accurate classification, origin records, commercial documentation, and applicable agency requirements, it gives the importer a stronger basis for demonstrating that the shipment meets U.S. entry requirements.
USDA APHIS Phytosanitary Requirements for Hemp Seed
Hemp seed imports can involve requirements beyond ordinary customs clearance, particularly when seed is being imported for planting. The regulatory pathway can differ depending on the purpose of the seed, its country of origin, and the applicable USDA requirements. Importers should determine these requirements before shipment rather than assuming that all hemp seed is treated the same way.
When phytosanitary certification applies
A phytosanitary certificate may be required when hemp seed is imported for planting or other agricultural purposes. The certificate provides information concerning the plant material and helps establish that the shipment meets applicable plant-health requirements.
Importers should determine whether certification is required for the specific commodity and country of origin before the shipment leaves the exporting country. Requirements can vary by origin and intended use, so businesses should not rely on documentation used for a previous shipment from a different country.
Seed for planting versus seed for consumption
The intended use of hemp seed is an important distinction. Seed for planting can be subject to agricultural and plant-health requirements that may not apply in the same way to seed imported for consumption.
Businesses importing seed for planting should therefore establish the applicable USDA APHIS requirements before arranging transportation. They should also maintain documentation clearly identifying the intended use of the seed.
Seed imported for food purposes should be evaluated under the requirements applicable to food imports, including any relevant FDA requirements, rather than assuming that the rules governing planting material automatically apply.
Country-specific import restrictions
Hemp seed requirements can vary depending on the country from which the seed is imported. Certain origins may have specific plant-health restrictions, certification requirements, or additional conditions.
Importers should verify the requirements applicable to both the commodity and country of origin before shipping. This is especially important for first-time suppliers, as documentation requirements for one origin should not automatically be applied to another.
Plant Pest and Disease Management Program considerations
USDA APHIS requirements are designed in part to prevent the introduction of plant pests and diseases into the United States. Hemp seed imported for planting can therefore require additional scrutiny compared with processed hemp products that no longer present the same agricultural risks.
Importers should establish the applicable APHIS pathway early and ensure that required certificates, permits, and supporting documentation are available before the shipment reaches the border.
State-Level Compliance Layer
Federal clearance is not necessarily the end of the compliance process for hemp businesses. Depending on the product and its destination, state-level requirements may apply after the goods enter the United States.
How state hemp programs interact with federal framework
States can establish their own hemp programs and may impose requirements affecting products distributed or sold within their jurisdiction. These requirements can concern product composition, testing, labeling, registration, and other aspects of commercial distribution.
An importer should therefore distinguish between federal admissibility and state-level market compliance. A product that is accepted by CBP does not automatically mean that it can be marketed without restriction in every state.
States with restrictive frameworks on intoxicating hemp products
State approaches to intoxicating hemp products can vary considerably. Some jurisdictions have adopted more restrictive frameworks for products containing cannabinoids that may produce intoxicating effects.
This is particularly important for importers dealing with products such as delta-8 THC and similar derivatives. Businesses should review the rules of the states where products will ultimately be sold or distributed rather than assuming that federal treatment determines the requirements in every destination state.
Multi-state distribution compliance
Businesses distributing hemp-derived products across multiple states may need to maintain a compliance system that accounts for differences between jurisdictions.
A product that meets the requirements of one state may require different labeling, registration, testing, or formulation in another. Importers should identify destination states before committing to large commercial shipments and maintain records demonstrating compliance with the applicable state requirements.
State product registration requirements
Some states may require registration or other approvals for particular hemp-derived products. Importers should verify whether their product category is subject to such requirements before distribution.
This is especially important for finished consumer products, where state-level requirements can exist alongside FDA requirements. A single federal customs clearance strategy may therefore not be sufficient for a nationwide distribution model.
Product-Specific Import Pathways
Hemp is not a single customs or regulatory category. The requirements that apply to an imported shipment can differ substantially depending on whether the merchandise is raw fiber, seed, a finished consumer product, or a cannabinoid extract.
Industrial hemp fiber and hurds
Industrial hemp fiber and hurds are generally associated with non-intoxicating industrial applications. Importers should establish the appropriate HTS classification and determine whether any USDA or other agency requirements apply based on the form of the material.
The commercial use of the product can also affect classification, so importers should provide accurate product descriptions and specifications to their customs broker.
Hemp textiles and yarn
Hemp textiles and yarn require classification according to their degree of processing and final form. Products made from hemp fiber can therefore fall under different tariff provisions depending on whether the imported merchandise is raw fiber, yarn, fabric, or a finished textile.
Importers should avoid assuming that all textile products containing hemp share the same HTS classification.
Hempcrete and construction materials
Hempcrete and other hemp-based construction materials should be evaluated according to their composition and intended use. The fact that hemp is one component of a finished construction product does not necessarily determine the product’s HTS classification.
Commercial documentation should clearly identify the composition and intended application of the imported material.
Hemp seed for planting
Hemp seed intended for planting requires particular attention because USDA APHIS requirements may apply. Importers should establish whether phytosanitary certification or other documentation is required for the specific country of origin before shipment.
Hemp seed for food
Hemp seed imported for food purposes follows a different commercial pathway from seed intended for planting. Importers should evaluate applicable FDA requirements in addition to customs classification and any agricultural requirements that apply to the particular product.
Hemp-derived CBD
Hemp-derived CBD products require careful evaluation because their federal hemp status does not automatically resolve FDA compliance questions. The product’s formulation, intended use, labeling, claims, and cannabinoid content should all be reviewed before importation.
Importers should also ensure that laboratory documentation supports the product’s composition and regulatory status.
Intoxicating hemp derivatives before November 12, 2026
Products such as certain delta-8 and delta-10 THC products require particular attention during the transition to the November 12, 2026 definition reset. Their treatment under the current federal framework can differ from the treatment expected after the new definition takes effect.
Importers dealing with these products should evaluate shipment timing, product formulation, laboratory testing, and future regulatory exposure rather than assuming that the current treatment will continue indefinitely.
Common Compliance Issues and Enforcement Patterns
Hemp imports can encounter problems when businesses treat customs clearance as a simple tariff-classification exercise. The most significant risks often arise from discrepancies between the product description, laboratory documentation, declared classification, origin, and applicable regulatory requirements.
Product exceeding delta-9 THC threshold
Under the current federal framework, exceeding the applicable 0.3% delta-9 THC threshold can prevent material from qualifying as hemp. Importers should therefore have reliable testing documentation available before shipment.
Missing or inadequate Certificate of Analysis
A missing, outdated, or insufficient COA can make it difficult to demonstrate the composition of the imported merchandise. Batch-specific documentation and appropriate laboratory testing are particularly important for cannabinoid products.
Misclassification triggering wrong regulatory pathway
Using an incorrect HTS classification can affect both duty treatment and the regulatory review associated with the shipment. Classification should be based on the actual characteristics and intended use of the merchandise.
Country of origin documentation failures
Importers should maintain records supporting the declared country of origin. This can affect tariff treatment and is particularly important where goods move through multiple countries before entering the United States.
FDA warning letters for CBD product claims
FDA enforcement has included action concerning CBD products and problematic health-related claims. Importers should review product labels and marketing materials before shipment rather than assuming that customs admissibility establishes FDA compliance.
What to do if a shipment is detained
If CBP or another federal agency detains a hemp shipment, the importer should promptly determine the reason for the detention and provide the requested documentation. Relevant records may include the commercial invoice, HTS classification support, COA, origin documentation, product specifications, and applicable permits or certificates.
Working with a customs broker and relevant regulatory professionals can help the importer identify the issue and respond efficiently.
Frequently Asked Questions About Importing Hemp into the U.S.
Is it legal to import hemp into the United States in 2026?
Qualifying hemp can be legally imported under the federal framework, but importers must satisfy applicable customs, USDA, FDA, DEA, and CBP requirements. The product must meet the federal definition of hemp and any additional requirements applicable to its category.
What is the current federal definition of hemp?
Under 7 U.S.C. § 1639o, hemp includes Cannabis sativa L. and qualifying parts, derivatives, extracts, cannabinoids, and isomers that meet the federal delta-9 THC threshold.
What changes on November 12, 2026?
The federal definition is scheduled to change from the current delta-9 THC framework to a total tetrahydrocannabinols standard, potentially affecting certain intoxicating hemp-derived products.
Do I need DEA registration?
Not every hemp importer requires DEA registration. Qualifying hemp is treated differently from controlled substances, but DEA requirements can become relevant where products fall outside the federal hemp definition or otherwise fall under controlled-substance rules.
Do I need USDA approval?
USDA requirements depend on the nature of the hemp product and its production or agricultural characteristics. Hemp seed and other agricultural materials may require additional USDA APHIS documentation or certification.
What HTS code applies?
There is no single HTS code for all hemp products. Classification depends on the merchandise, with the brief identifying provisions including 1207.99, 1211.90, 5302, 3301.90, 3304, and 5911.10 for different hemp product categories.
What duty rate applies?
The duty rate depends on the product’s HTS classification and country of origin. Additional tariff measures may also apply.
Do Chinese hemp imports face Section 301 tariffs?
Certain Chinese-origin hemp products may be subject to Section 301 additional duties depending on their HTS classification and the applicable tariff measures.
What documentation is required?
Requirements vary by product, but importers should generally be prepared with commercial documentation, classification and origin information, and any applicable COAs, permits, certificates, or agency documentation.
What is a COA and why does CBP care?
A Certificate of Analysis provides laboratory evidence about a product’s composition. For cannabinoid products, it can help establish compliance with applicable THC requirements and support the information provided during customs or regulatory review.
Can I import delta-8 THC products in 2026?
The regulatory treatment of delta-8 THC products requires careful evaluation under the current federal framework, and the scheduled November 12, 2026 definition change creates additional uncertainty. Importers should review each product individually rather than assuming all hemp-derived delta-8 products will remain eligible.
What happens if a shipment exceeds 0.3% delta-9 THC?
A product exceeding the applicable federal hemp threshold may not qualify as hemp under the current definition. This can create significant admissibility and controlled-substance concerns and should be addressed before shipment.
Do state requirements apply after federal clearance?
Yes. State-level requirements may apply to products after they enter the United States, particularly for products distributed or sold within individual states.
What is the difference between hemp and marijuana?
The federal distinction primarily turns on the statutory definition and applicable THC requirements. Qualifying hemp was removed from the Controlled Substances Act by the 2018 Farm Bill, while marijuana remains subject to federal controlled-substance regulation.
Do I need a customs broker?
A customs broker is not simply a substitute for the importer’s legal responsibilities, but professional customs support can be valuable for classification, entry filing, documentation, and coordination with CBP and other agencies.
How does the April 2026 DOJ marijuana rescheduling affect hemp imports?
The brief states that the April 22, 2026 DOJ action concerning marijuana’s Schedule III treatment does not change the status of hemp that qualifies under 7 U.S.C. § 1639o.
Bringing It Together
Importing hemp into the United States requires a coordinated approach to customs and regulatory compliance. A business must first establish whether its product qualifies as hemp under the applicable federal definition, then determine the correct HTS classification, country of origin, duty treatment, and agency requirements.
The process becomes more important as the November 12, 2026 hemp definition reset approaches. Importers handling cannabinoid products should review their product lines, testing documentation, suppliers, shipment schedules, and destination-state requirements well in advance.
For agricultural hemp and seed, USDA APHIS requirements may be central to the import pathway. For consumer products, FDA requirements can apply independently of the product’s status as hemp. DEA considerations become relevant where merchandise falls outside the federal hemp definition, while CBP coordinates the customs clearance process at the border.
The safest approach is to establish compliance before the shipment leaves the country of export. Accurate classification, reliable COAs, origin documentation, appropriate permits or certificates, and clear product specifications can help reduce the risk of detention, refusal, unexpected duties, and costly delays.
If you are importing hemp or hemp-derived products into the United States, a customs broker can help you navigate classification, documentation, entry filing, and coordination with the agencies involved in the import process.
